8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

Form 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 13, 2012

 

 

Streamline Health Solutions, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   0-28132   31-1455414

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

1230 Peachtree St. NE,

Suite 1000, Atlanta, GA

  30309
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code (404) 446-0050

 

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION

On December 13, 2012, Streamline Health Solutions, Inc. (“Streamline Health”) issued the press release attached hereto as Exhibit 99.1, which press release contains financial information about Streamline Health’s first fiscal quarter ended October 31, 2012. Following issuance of that press release and approval of the information contained in that press release by the company’s independent auditors, the auditors determined that there should be a $3,600,000 non-cash reduction in the company’s tax valuation allowance in the three and nine months ended October 31, 2012 relating to deferred tax liabilities recorded in conjunction with the company’s acquisition of Meta Health Technology. This reduction in the tax valuation allowance resulted in positive adjustments to the net income and earnings per share previously reported by the company. On December 14, 2012, the company issued the updated press release attached hereto as Exhibit 99.2. The information hereunder shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference into a filing under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits

 

EXHIBIT

NUMBER

   DESCRIPTION
99.1    Third Quarter Earnings News Release of Streamline Health Solutions, Inc. dated December 13, 2012.
99.2    Updated Third Quarter Earnings News Release of Streamline Health Solutions, Inc. dated December 14, 2012.

 

2


SIGNATURES

Pursuant to the requirements of the Securities Act of 1934, registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    Streamline Health Solutions, Inc.

Date: December 14, 2012

            By:  

/s/ Stephen H. Murdock

        Stephen H. Murdock
        Chief Financial Officer

 

3


INDEX TO EXHIBITS

 

Exhibit No.

  

Description of Exhibit

99.1    Third Quarter Earnings News Release of Streamline Health Solutions, Inc. dated December 13, 2012.
99.2    Updated Third Quarter Earnings News Release of Streamline Health Solutions, Inc. dated December 14, 2012.

 

4

EX-99.1

Exhibit 99.1

 

LOGO

News Release

Visit our website at: www.streamlinehealth.net

STREAMLINE HEALTH® REPORTS THIRD QUARTER FISCAL YEAR 2012

FINANCIAL RESULTS

52% Increase in Revenue; 49% Increase in Adjusted EBITDA*

Atlanta, Georgia – December 13, 2012 – Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of enterprise content management, business analytics, computer assisted coding (CAC), and clinical documentation improvement (CDI) solutions for healthcare providers, today announced financial results for the third quarter of fiscal year 2012, which ended October 31, 2012.

Revenues for the three-month period ended October 31, 2012, were $6,534,000 as compared to $4,312,000 in the comparable period of fiscal 2011. The quarterly increase was primarily attributable to revenues provided by increases in recurring SaaS revenues.

“We had a very successful third quarter,” said Robert E. Watson, President and Chief Executive Officer of Streamline Health. “Revenue and adjusted EBITDA continued to grow. Additionally, we closed the acquisition of Meta Health Technology which expanded our solutions portfolio significantly and we completed a very significant financing. It is important to note that we did not forecast these major accomplishments when we began this fiscal year. Consequently, the accounting treatment for these transactions has negatively impacted our GAAP EPS for this fiscal year. However, these strategic moves were major steps in positioning our company for further growth, enabling us to invest in world-class healthcare information technology solutions, and helping our clients improve their financial outcomes.”

Highlights for the quarter included:

 

   

Recorded net loss of $1,165,000; of which $494,000 is attributable to non-recurring transaction related expenses; resulting in an adjusted non-GAAP net loss of $671,000

 

   

Adjusted EBITDA* for third quarter 2012 was $1.6 million, an increase of 49% over third quarter 2011;

 

   

Software as a Service (SaaS) revenues for the quarter increased 23% over the prior year comparable quarter, excluding $821,000 of incremental SaaS revenue from the acquired operations of Interpoint Partners;

 

   

New sales bookings for the quarter were $2.9 million;

 

   

Maintenance and SaaS contract renewals for the quarter were $2.5 million;

 

   

Backlog at the end of the quarter was $48.7 million.

New sales bookings for the second quarter were $2.9 million, primarily consisting of professional services and software as a service contracts. Maintenance and SaaS renewals or extensions were $2.5 million. For the comparable prior period in 2011, new sales bookings were $1.4 million and renewals or extensions were $1.6 million.


Backlog at October 31, 2012 was $48.7 million, compared with $32.2 million at July 31, 2012. The increase in the current backlog reflects significant new SaaS contract signings as well as current clients purchasing additional solutions.

Conference Call Information

Interested parties can access the call by dialing 888-427-9419 and then entering the passcode 8521046. A live webcast will also be available by clicking this link: bit.ly/VrdPro

A replay of the conference call will be available from Thursday, December 13, 2012 at 2:00 p.m. EST to Tuesday, December 18, 2012 at 2:00 p.m. EST by dialing 888-203-1112 and entering passcode 8521046.

*    Non-GAAP Financial Measures

Streamline Health reports its financial results in accordance with generally accepted accounting principles in the United States (“GAAP”). Streamline Health’s management also evaluates and makes operating decisions using various other measures. One such measure is adjusted EBITDA, which is a non-GAAP financial measure. Streamline Health’s management believes that these measures provide useful supplemental information regarding the performance of Streamline Health’s business operations.

Streamline Health defines “adjusted EBITDA” as net earnings (loss) plus interest expense, tax expense, depreciation and amortization expense of tangible and intangible assets, stock-based compensation expense, and non-recurring transaction costs. A table illustrating this measure is included in this publication.

About Streamline Health

Streamline Health Solutions, Inc. (NASDAQ: STRM) is a leading provider of SaaS-based healthcare information technology (HCIT) solutions for hospitals and physician groups with offices in Atlanta, Cincinnati and New York. The company’s comprehensive suite of solutions includes: enterprise content management (ECM), business analytics, integrated workflow systems, clinical documentation improvement (CDI), and computer assisted coding (CAC). Across the revenue cycle, these solutions offer healthcare enterprises a flexible, customizable way to communicate between disparate departments and information systems to improve processes, boost productivity, and optimize clinical, administrative and financial performance. For more information, please visit our website at

http://www.streamlinehealth.net.


Safe Harbor statement under the Private Securities Litigation Reform Act of 1995

Statements made by Streamline Health Solutions, Inc. that are not historical facts are forward-looking statements that are subject to risks and uncertainties and are no guarantee of future performance. The forward looking statements contained herein are subject to certain risks, uncertainties and important factors that could cause actual results to differ materially from those reflected in the forward-looking statements, included herein. These risks and uncertainties include, but are not limited to, the timing of contract negotiations and execution of contracts and the related timing of the revenue recognition related thereto, the potential cancellation of existing contracts or clients not completing projects included in the backlog, the impact of competitive products and pricing, product demand and market acceptance, new product development, key strategic alliances with vendors that resell the Company’s products, the ability of the Company to control costs, availability of products obtained from third party vendors, the healthcare regulatory environment, potential changes in legislation, regulation and government funding affecting the healthcare industry, healthcare information systems budgets, availability of healthcare information systems trained personnel for implementation of new systems, as well as maintenance of legacy systems, fluctuations in operating results, effects of critical accounting policies and judgments, changes in accounting policies or procedures as may be required by the Financial Accountings Standards Board or other similar entities, changes in economic, business and market conditions impacting the healthcare industry, the markets in which the Company operates and nationally, and the Company’s ability to maintain compliance with the terms of its credit facilities, and other risks detailed from time to time in the Streamline Health Solutions, Inc. filings with the U. S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward looking statements, which reflect management’s analysis only as of the date hereof. The Company undertakes no obligation to publicly release the results of any revision to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

 

Company Contact:

Ashley Moore

Director, Marketing

(404)-446-2057

ashley.moore@streamlinehealth.net

  

Investor Contacts:

Randy Salisbury

Investor Relations

(404)-229-4242

randy.salisbury@streamlinehealth.net

    

BPC Financial Marketing

John Baldissera

800-368-1217


STREAMLINE HEALTH SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

Three and Nine Months Ended October 31,

(Unaudited)

 

     Three Months     Nine Months  
     2012     2011     2012     2011  

Revenues:

        

Systems sales

   $ 290,294      $ 232,395      $ 719,495      $ 526,597   

Professional services

     1,089,814        833,592        3,153,672        2,708,824   

Maintenance and support

     3,148,442        2,279,886        7,797,263        6,558,484   

Software as a service

     2,005,813        966,218        5,358,120        2,804,141   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total revenues

     6,534,363        4,312,091        17,028,550        12,598,046   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating expenses:

        

Cost of systems sales

     717,901        583,388        1,936,761        1,751,890   

Cost of professional services

     854,997        572,056        1,910,951        1,923,576   

Cost of maintenance and support

     918,750        513,868        2,349,745        1,651,884   

Cost of software as a service

     550,875        480,368        1,849,962        1,334,659   

Selling, general and administrative

     2,926,830        1,494,891        6,800,794        4,742,084   

Product research and development

     866,659        303,973        1,833,865        1,063,903   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     6,836,012        3,948,544        16,682,078        12,467,996   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income (loss)

     (301,649     363,547        346,472        130,050   

Other income (expense):

        

Interest expense

     (895,142     (25,896     (1,494,161     (67,529

Miscellaneous income (expenses)

     43,549        (36,885     55,805        (42,155
  

 

 

   

 

 

   

 

 

   

 

 

 

Earnings (loss) before income taxes

     (1,153,242     300,766        (1,091,884     20,366   

Income tax expense

     (11,733     (5,000     (44,733     (12,315
  

 

 

   

 

 

   

 

 

   

 

 

 

Net earnings (loss)

   $ (1,164,975   $ 295,766      $ (1,136,617   $ 8,051   
  

 

 

   

 

 

   

 

 

   

 

 

 

Less: deemed dividends on Preferred Shares

     (139,133       (139,133  
  

 

 

     

 

 

   

Net earnings (loss) attributable to common shareholders

   $ (1,304,108     $ (1,275,750  
  

 

 

     

 

 

   

Basic net earnings (loss) per common share

   $ (0.11   $ 0.03      $ (0.11   $ 0.00   
  

 

 

   

 

 

   

 

 

   

 

 

 

Number of shares used in basic per common share computation

     12,393,314        9,943,567        11,346,415        9,823,937   
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted net earnings (loss) per common share

   $ (0.11   $ 0.03      $ (0.11   $ 0.00   
  

 

 

   

 

 

   

 

 

   

 

 

 

Number of shares used in diluted per common share computation

     12,393,314        9,958,947        11,346,415        9,837,750   
  

 

 

   

 

 

   

 

 

   

 

 

 


STREAMLINE HEALTH SOLUTIONS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

Assets

 

     (Unaudited)
October 31,
2012
    January 31,
2012
 

Current assets:

    

Cash and cash equivalents

   $ 10,528,695      $ 2,243,054   

Accounts receivable, net of allowance for doubtful accounts of $134,000 and $100,000, respectively

     3,389,738        4,484,605   

Contract receivables

     648,736        430,370   

Prepaid hardware and third party software for future delivery

     22,777        38,193   

Prepaid client maintenance contracts

     1,038,035        788,917   

Prepaid and other assets

     555,310        256,104   

Deferred income taxes

     326,618        167,000   
  

 

 

   

 

 

 

Total current assets

     16,509,909        8,408,243   
  

 

 

   

 

 

 

Non-current assets:

    

Property and equipment:

    

Computer equipment

     3,418,500        2,892,885   

Computer software

     2,196,236        2,131,730   

Office furniture, fixtures and equipment

     818,231        756,375   

Leasehold improvements

     693,890        667,000   
  

 

 

   

 

 

 
     7,126,857        6,447,990   

Accumulated depreciation and amortization

     (5,778,675     (5,232,321
  

 

 

   

 

 

 

Property and equipment, net

     1,348,182        1,215,669   
  

 

 

   

 

 

 

Contract receivables, less current portion

     142,021        221,596   

Capitalized software development costs, net of accumulated amortization of $16,733,274 and $14,805,236, respectively

     13,119,354        9,830,175   

Intangible assets, net

     8,517,084        417,666   

Deferred financing cost, net

     1,211,912        145,857   

Goodwill

     12,038,226        4,060,504   

Other, including deferred income taxes of $711,000 and $711,000, respectively

     1,077,857        841,348   
  

 

 

   

 

 

 

Total non-current assets

     37,454,636        16,732,815   
  

 

 

   

 

 

 
   $ 53,964,545      $ 25,141,058   
  

 

 

   

 

 

 


STREAMLINE HEALTH SOLUTIONS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

Liabilities and Stockholders’ Equity

 

     (Unaudited)
October 31,
2012
    January 31,
2012
 

Current liabilities:

    

Accounts payable

   $ 832,657      $ 879,027   

Accrued compensation

     1,603,355        887,130   

Accrued other expenses

     1,373,307        479,526   

Deferred revenues

     6,262,960        6,496,938   

Contingent consideration for earn-out

     1,319,559        —     

Current portion of long-term debt

     1,250,000        —     
  

 

 

   

 

 

 

Total current liabilities

     12,641,838        8,742,621   
  

 

 

   

 

 

 

Non-current liabilities:

    

Term loans

     12,750,000        4,120,000   

Convertible note payable, net of unamortized discount of $1,822,255

     3,877,322        3,000,000   

Warrants liability

     4,138,783        —     

Lease incentive liability

     101,453        47,193   

Contingent consideration for earn-out, less current portion

     —          1,232,720   

Deferred income tax liability

     4,602,230        —     
  

 

 

   

 

 

 

Total non-current liabilities

     25,469,788        8,399,913   
  

 

 

   

 

 

 

Total liabilities

     38,111,626        17,142,534   
  

 

 

   

 

 

 

Series A 0% Convertible redeemable preferred stock, $.01 par value per share, $7,250,355 redemption value, 5,000,000 shares authorized, 2,416,785 shares issued

     2,979,170        —     

Stockholders’ equity:

    

Common stock, $.01 par value per share, 25,000,000 shares authorized, 12,582,598 and 10,433,716 shares issued and outstanding, respectively

     125,826        104,338   

Additional paid in capital

     44,351,334        38,360,980   

Accumulated deficit

     (31,603,411     (30,466,794
  

 

 

   

 

 

 

Total stockholders’ equity

     12,873,749        7,998,524   
  

 

 

   

 

 

 
   $ 53,964,545      $ 25,141,058   
  

 

 

   

 

 

 


STREAMLINE HEALTH SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

Nine Months Ended October 31,

(Unaudited)

 

     2012     2011  

Operating activities:

    

Net earnings (loss)

   $ (1,136,617   $ 8,051   

Adjustments to reconcile net earnings (loss) to net cash

    

provided by operating activities, net of effect of acquisition:

    

Depreciation and amortization

     2,847,665        2,008,432   

Loss on disposal of equipment

     —          26,667   

Stock-based compensation expense

     645,407        529,104   

Provision for accounts receivable

     —          40,000   

Amortization of debt discount

     111,584        —     

Fair value adjustment for contingent earnout

     86,839        —     

Net loss from conversion of convertible notes

     56,682        —     

Change in assets and liabilities:

    

Accounts and contract receivables

     (1,351,935     419,517   

Other assets

     (482,785     (89,066

Accounts payable

     (137,107     161,609   

Accrued expenses

     947,630        (574,012

Deferred revenues

     881,677        (1,904,641
  

 

 

   

 

 

 

Net cash provided by operating activities

     2,469,040        625,661   
  

 

 

   

 

 

 

Investing activities:

    

Purchases of property and equipment

     (546,061     (245,262

Capitalization of software development costs

     (1,571,420     (1,970,000

Payment for acquisition, net of cash acquired

     (12,161,634     —     
  

 

 

   

 

 

 

Net cash used in investing activities

     (14,279,115     (2,215,262
  

 

 

   

 

 

 

Financing activities:

    

Net change in borrowings

     9,880,000        550,000   

Payment of deferred financing costs

     (1,246,107     —     

Proceeds from exercise of stock options and stock purchase plan

     161,823        92,711   

Proceeds from private placement

     12,000,000        —     

Payment of success fees

     (700,000     —     

Payments on capital lease obligation

     —          (156,621
  

 

 

   

 

 

 

Net cash provided by financing activities

     20,095,716        486,090   
  

 

 

   

 

 

 

Increase (decrease) in cash and cash equivalents

     8,285,641        (1,103,511

Cash and cash equivalents at beginning of period

     2,243,054        1,403,949   
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 10,528,695      $ 300,438   
  

 

 

   

 

 

 

Supplemental cash flow disclosures:

    

Interest paid

   $ 1,181,929      $ 61,532   
  

 

 

   

 

 

 

Income taxes paid

   $ 78,041      $ 19,136   
  

 

 

   

 

 

 

Supplemental Disclosure of Non-Cash Financing and Investing Activities:

- In June 2012, the $3,000,000 convertible note and accrued interest was converted to 1,529,729 common shares at $2.00 per share.
- In August 2012, we issued 393,086 shares of our common stock at a price of $4.07, as part of the Meta acquisition purchase price.
- In October 2012, we issued approximately 200,000 common stock warrants, convertible into common stock shares at $4.06 per share.
- During the third quarter of 2012, we recorded approximately $139,000 of deemed dividends from preferred shares discount accretion.


STREAMLINE HEALTH SOLUTIONS, INC.

Backlog

(Unaudited)

Table A

Backlog

 

     October 31, 2012      January 31, 2012      October 31, 2011  

Streamline Health Software Licenses

   $ 3,650,000       $ 181,000       $ 67,000   

Hardware and Third Party Software

     84,000         194,000         190,000   

Professional Services

     4,348,000         5,945,000         4,946,000   

Software as a service

     19,117,000         10,542,000         6,237,000   

Maintenance and support

     21,535,000         10,504,000         5,374,000   
  

 

 

    

 

 

    

 

 

 

Total

   $ 48,734,000       $ 27,366,000       $ 16,814,000   
  

 

 

    

 

 

    

 

 

 


STREAMLINE HEALTH SOLUTIONS, INC.

Bookings

(Unaudited)

Table B

New bookings (1)

 

     Three Months Ended
October 31, 2012
 
     Value      % of Total Bookings  

Streamline Health Software licenses

   $ —           —  

Software as a service

     2,200,000         76

Maintenance and support

     —           —  

Professional services

     684,000         23

Hardware & third party software

     20,000         1
  

 

 

    

 

 

 

Total bookings

   $ 2,904,000         100
  

 

 

    

 

 

 
     Nine Months Ended
October 31, 2012
 
     Value      % of Total Bookings  

Streamline Health Software licenses

   $ 50,000         —  

Software as a service

     9,757,000         86

Maintenance and support

     64,000         1

Professional services

     1,160,000         10

Hardware & third party software

     368,000         3
  

 

 

    

 

 

 

Total bookings

   $ 11,399,000         100
  

 

 

    

 

 

 

 

(1) Bookings are the aggregate of signed contracts and/or completed customer purchase orders approved and accepted by the Company as binding commitments to purchase its products and/or services. New bookings do not include maintenance services as these tend to be recurring in nature on an annual or more frequent basis.


Reconciliation of Non-GAAP Financial Measures

(Unaudited)

Table C

This press release contains a non-GAAP financial measure under the rules of the U.S. Securities and Exchange Commission for adjusted EBITDA. This non-GAAP information supplements and is not intended to represent a measure of performance in accordance with disclosures required by generally accepted accounting principles. Non-GAAP financial measures are used internally to manage the business, such as in establishing an annual operating budget. Non-GAAP financial measures are used by Streamline Health’s management in its operating and financial decision-making because management believes these measures reflect ongoing business in a manner that allows meaningful period-to-period comparisons. Accordingly, the Company believes it is useful for investors and others to review both GAAP and non-GAAP measures in order to (a) understand and evaluate current operating performance and future prospects in the same manner as management does and (b) compare in a consistent manner the company’s current financial results with past financial results. The primary limitations associated with the use of non-GAAP financial measures are that these measures may not be directly comparable to the amounts reported by other companies and they do not include all items of income and expense that affect operations. The Company’s management compensates for these limitations by considering the company’s financial results and outlook as determined in accordance with GAAP and by providing a detailed reconciliation of the non-GAAP financial measures to the most directly comparable GAAP measures in the tables attached to this press release.

Reconciliation of net earnings (loss) to non-GAAP adjusted EBITDA (in thousands)

 

Adjusted EBITDA Reconciliation    Three Months Ended,      Nine Months Ended,  
     October 31,
2012
    October 31,
2011
     October 31,
2012
    October 31,
2011
 

Net earnings (loss)

   $ (1,165   $ 296       $ (1,137   $ 8   

Interest expense

     895        26         1,494        68   

Income tax expense

     12        5         45        12   

Depreciation and other amortization

     184        163         548        553   

Amortization of capitalized software development costs

     708        454         1,930        1,455   

Amortization of intangible assets

     229        —           254        —     
  

 

 

   

 

 

    

 

 

   

 

 

 

EBITDA

     863        944         3,134        2,096   
  

 

 

   

 

 

    

 

 

   

 

 

 

Stock-based compensation expense

     245        133         645        529   

Transaction expenses

     494        —           1,043        —     
  

 

 

   

 

 

    

 

 

   

 

 

 

Adjusted EBITDA

   $ 1,602      $ 1,077       $ 4,822      $ 2,625   
  

 

 

   

 

 

    

 

 

   

 

 

 

Adjusted EBITDA per diluted share

         

Earnings (loss) per share—diluted

   $ (0.11   $ 0.03       $ (0.11   $ 0.00   
  

 

 

   

 

 

    

 

 

   

 

 

 

Adjusted EBITDA per adjusted diluted share

   $ 0.10      $ 0.11       $ 0.33      $ 0.27   
  

 

 

   

 

 

    

 

 

   

 

 

 

Diluted weighted average shares

     12,393,314        9,958,947         11,346,415        9,837,750   

Includable incremental shares—adjusted EBITDA (1)

     3,683,574        —           3,117,999        —     
  

 

 

   

 

 

    

 

 

   

 

 

 

Adjusted diluted shares

     16,076,888        9,958,947         14,464,414        9,837,750   
  

 

 

   

 

 

    

 

 

   

 

 

 

 

(1) Includes preferred shares on an as-if-converted basis and common stock warrants and options under the treasury stock method.
EX-99.2

Exhibit 99.2

 

LOGO

News Release

Visit our website at: www.streamlinehealth.net

STREAMLINE HEALTH® REPORTS IMPROVED INCOME AND

EPS FOR THIRD QUARTER 2012

Adjustment in Tax Valuation Allowance Improves Quarterly Net Income to

$2.3 Million and EPS to $.18

Atlanta, Georgia – December 14, 2012 – Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of enterprise content management, business analytics, computer assisted coding (CAC), and clinical documentation improvement (CDI) solutions for healthcare providers, today announced that following the release of its third quarter 2012 earnings on December 13, 2012, after having received approval for that press release from its independent auditors, the company has been encouraged by its auditors to take a non-cash adjustment in its tax valuation allowance, as a result of the deferred tax liabilities recorded in conjunction with the Meta Health Technology acquisition, thereby altering its net income and earnings per share (EPS) performance for the quarter.

The adjustment in the tax valuation allowance also increased the company’s year-to-date net income and EPS, to $2.3 million and $.20 respectively.

About Streamline Health

Streamline Health Solutions, Inc. (NASDAQ: STRM) is a leading provider of SaaS-based healthcare information technology (HCIT) solutions for hospitals and physician groups with offices in Atlanta, Cincinnati, and New York. The company’s comprehensive suite of solutions includes: enterprise content management (ECM), business analytics, integrated workflow systems, clinical documentation improvement (CDI), and computer assisted coding (CAC). Across the revenue cycle, these solutions offer healthcare enterprises a flexible, customizable way to communicate between disparate departments and information systems to improve processes, boost productivity, and optimize clinical, administrative and financial performance. For more information, please visit our website at http://www.streamlinehealth.net.

* Non-GAAP Financial Measures

Streamline Health reports its financial results in accordance with generally accepted accounting principles in the United States (“GAAP”). Streamline Health’s management also evaluates and makes operating decisions using various other measures. One such measure is adjusted EBITDA, which is a non-GAAP financial measure. Streamline Health’s management believes that these measures provide useful supplemental information regarding the performance of Streamline Health’s business operations.

Streamline Health defines “adjusted EBITDA” as net earnings (loss) plus interest expense, tax expense, depreciation and amortization expense of tangible and intangible assets, stock-based compensation expense, and non-recurring transaction costs. A table illustrating this measure is included in this publication.


Safe Harbor statement under the Private Securities Litigation Reform Act of 1995

Statements made by Streamline Health Solutions, Inc. that are not historical facts are forward-looking statements that are subject to risks and uncertainties and are no guarantee of future performance. The forward looking statements contained herein are subject to certain risks, uncertainties and important factors that could cause actual results to differ materially from those reflected in the forward-looking statements, included herein. These risks and uncertainties include, but are not limited to, the timing of contract negotiations and execution of contracts and the related timing of the revenue recognition related thereto, the potential cancellation of existing contracts or clients not completing projects included in the backlog, the impact of competitive products and pricing, product demand and market acceptance, new product development, key strategic alliances with vendors that resell the Company’s products, the ability of the Company to control costs, availability of products obtained from third party vendors, the healthcare regulatory environment, potential changes in legislation, regulation and government funding affecting the healthcare industry, healthcare information systems budgets, availability of healthcare information systems trained personnel for implementation of new systems, as well as maintenance of legacy systems, fluctuations in operating results, effects of critical accounting policies and judgments, changes in accounting policies or procedures as may be required by the Financial Accountings Standards Board or other similar entities, changes in economic, business and market conditions impacting the healthcare industry, the markets in which the Company operates and nationally, and the Company’s ability to maintain compliance with the terms of its credit facilities, and other risks detailed from time to time in the Streamline Health Solutions, Inc. filings with the U. S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward looking statements, which reflect management’s analysis only as of the date hereof. The Company undertakes no obligation to publicly release the results of any revision to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

 

Company Contact:

Ashley Moore

Director, Marketing

(404)-446-2057

ashley.moore@streamlinehealth.net

  

Investor Contacts:

Randy Salisbury

Investor Relations

(404)-229-4242

randy.salisbury@streamlinehealth.net

  

 

BPC Financial Marketing

John Baldissera

800-368-1217


STREAMLINE HEALTH SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

Three and Nine Months Ended October 31,

(Unaudited)

 

     Three Months     Nine Months  
     2012     2011     2012     2011  

Revenues:

        

Systems sales

   $ 290,294      $ 232,395      $ 719,495      $ 526,597   

Professional services

     1,089,814        833,592        3,153,672        2,708,824   

Maintenance and support

     3,148,442        2,279,886        7,797,263        6,558,484   

Software as a service

     2,005,813        966,218        5,358,120        2,804,141   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total revenues

     6,534,363        4,312,091        17,028,550        12,598,046   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating expenses:

        

Cost of systems sales

     717,901        583,388        1,936,761        1,751,890   

Cost of professional services

     854,997        572,056        1,910,951        1,923,576   

Cost of maintenance and support

     918,750        513,868        2,349,745        1,651,884   

Cost of software as a service

     550,875        480,368        1,849,962        1,334,659   

Selling, general and administrative

     2,926,830        1,494,891        6,800,794        4,742,084   

Product research and development

     866,659        303,973        1,833,865        1,063,903   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     6,836,012        3,948,544        16,682,078        12,467,996   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income (loss)

     (301,649     363,547        346,472        130,050   

Other income (expense):

        

Interest expense

     (895,142     (25,896     (1,494,161     (67,529

Miscellaneous income (expenses)

     43,549        (36,885     55,805        (42,155
  

 

 

   

 

 

   

 

 

   

 

 

 

Earnings (loss) before income taxes

     (1,153,242     300,766        (1,091,884     20,366   

Income tax benefit (expense)

     3,552,879        (5,000     3,519,879        (12,315
  

 

 

   

 

 

   

 

 

   

 

 

 

Net earnings

   $ 2,399,637      $ 295,766      $ 2,427,995      $ 8,051   
  

 

 

   

 

 

   

 

 

   

 

 

 

Less: deemed dividends on Series A Preferred Shares

     (139,133       (139,133  
  

 

 

     

 

 

   

Net earnings attributable to common shareholders

   $ 2,260,504        $ 2,288,862     
  

 

 

     

 

 

   

Basic net earnings per common share

   $ 0.18      $ 0.03      $ 0.20      $ 0.00   
  

 

 

   

 

 

   

 

 

   

 

 

 

Number of shares used in basic per common share computation

     12,393,352        9,943,567        11,346,428        9,823,937   
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted net earnings per common share

   $ 0.15      $ 0.03      $ 0.18      $ 0.00   
  

 

 

   

 

 

   

 

 

   

 

 

 

Number of shares used in diluted per common share computation

     15,365,238        9,958,947        12,417,256        9,837,750   
  

 

 

   

 

 

   

 

 

   

 

 

 


STREAMLINE HEALTH SOLUTIONS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

Assets

 

     (Unaudited)
October 31,
2012
    January 31,
2012
 

Current assets:

    

Cash and cash equivalents

   $ 10,528,695      $ 2,243,054   

Accounts receivable, net of allowance for doubtful accounts of $134,000 and $100,000, respectively

     3,389,738        4,484,605   

Contract receivables

     648,736        430,370   

Prepaid hardware and third party software for future delivery

     22,777        38,193   

Prepaid client maintenance contracts

     1,038,035        788,917   

Prepaid and other assets

     555,310        256,104   

Deferred income taxes

     —          167,000   
  

 

 

   

 

 

 

Total current assets

     16,183,291        8,408,243   
  

 

 

   

 

 

 

Non-current assets:

    

Property and equipment:

    

Computer equipment

     3,418,500        2,892,885   

Computer software

     2,196,236        2,131,730   

Office furniture, fixtures and equipment

     818,231        756,375   

Leasehold improvements

     693,890        667,000   
  

 

 

   

 

 

 
     7,126,857        6,447,990   

Accumulated depreciation and amortization

     (5,778,675     (5,232,321
  

 

 

   

 

 

 

Property and equipment, net

     1,348,182        1,215,669   
  

 

 

   

 

 

 

Contract receivables, less current portion

     142,021        221,596   

Capitalized software development costs, net of accumulated amortization of $16,733,274 and $14,805,236, respectively

     13,119,354        9,830,175   

Intangible assets, net

     8,517,084        417,666   

Deferred financing cost, net

     1,211,912        145,857   

Goodwill

     12,038,226        4,060,504   

Other, including deferred income taxes of $0 and $711,000, respectively

     366,857        841,348   
  

 

 

   

 

 

 

Total non-current assets

     36,743,636        16,732,815   
  

 

 

   

 

 

 
   $ 52,926,927      $ 25,141,058   
  

 

 

   

 

 

 


STREAMLINE HEALTH SOLUTIONS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

Liabilities and Stockholders’ Equity

 

     (Unaudited)
October 31,
2012
    January 31,
2012
 

Current liabilities:

    

Accounts payable

   $ 832,657      $ 879,027   

Accrued compensation

     1,603,355        887,130   

Accrued other expenses

     1,373,307        479,526   

Deferred revenues

     6,262,960        6,496,938   

Contingent consideration for earn-out

     1,319,559        —     

Current portion of long-term debt

     1,250,000        —     
  

 

 

   

 

 

 

Total current liabilities

     12,641,838        8,742,621   
  

 

 

   

 

 

 

Non-current liabilities:

    

Term loans

     12,750,000        4,120,000   

Convertible note payable, net of unamortized discount of $1,822,255 and $0, respectively

     3,877,322        3,000,000   

Warrants liability

     4,138,783        —     

Lease incentive liability

     101,453        47,193   

Contingent consideration for earn-out, less current portion

     —          1,232,720   
  

 

 

   

 

 

 

Total non-current liabilities

     20,867,558        8,399,913   
  

 

 

   

 

 

 

Total liabilities

     33,509,396        17,142,534   
  

 

 

   

 

 

 

Series A 0% Convertible Redeemable Preferred Stock, $.01 par value per share, $7,250,355 redemption value, 5,000,000 shares authorized, 2,416,785 shares issued

     2,979,170        —     

Stockholders’ equity:

    

Common stock, $.01 par value per share, 25,000,000 shares authorized, 12,582,598 and 10,433,716 shares issued and outstanding, respectively

     125,826        104,338   

Convertible Redeemable Preferred Stock, $0.01 par value per share, 1,000,000 authorized, no shares issued

     —          —     

Additional paid in capital

     44,351,334        38,360,980   

Accumulated deficit

     (28,038,799     (30,466,794
  

 

 

   

 

 

 

Total stockholders’ equity

     16,438,361        7,998,524   
  

 

 

   

 

 

 
   $ 52,926,927      $ 25,141,058   
  

 

 

   

 

 

 


STREAMLINE HEALTH SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

Nine Months Ended October 31,

(Unaudited)

 

     2012     2011  

Operating activities:

    

Net earnings

   $ 2,427,995      $ 8,051   

Adjustments to reconcile net earnings to net cash provided by operating activities, net of effect of acquisition:

    

Depreciation and amortization

     2,847,665        2,008,432   

Loss on disposal of equipment

     —          26,667   

Share-based compensation expense

     645,407        529,104   

Deferred tax benefit

     (3,564,612     —     

Provision for accounts receivable

     —          40,000   

Amortization of debt discount

     111,584        —     

Fair value adjustment for contingent earnout

     86,839        —     

Net loss from conversion of convertible note

     56,682        —     

Change in assets and liabilities:

    

Accounts and contract receivables

     (1,351,935     419,517   

Other assets

     (482,785     (89,066

Accounts payable

     (137,107     161,609   

Accrued expenses

     947,630        (574,012

Deferred revenues

     881,677        (1,904,641
  

 

 

   

 

 

 

Net cash provided by operating activities

     2,469,040        625,661   
  

 

 

   

 

 

 

Investing activities:

    

Purchases of property and equipment

     (546,061     (245,262

Capitalization of software development costs

     (1,571,420     (1,970,000

Payment for acquisition, net of cash acquired

     (12,161,634     —     
  

 

 

   

 

 

 

Net cash used in investing activities

     (14,279,115     (2,215,262
  

 

 

   

 

 

 

Financing activities:

    

Net change in borrowings

     9,880,000        550,000   

Payment of deferred financing costs

     (1,246,107     —     

Proceeds from exercise of stock options and stock purchase plan

     161,823        92,711   

Proceeds from private placement

     12,000,000        —     

Payment of success fee

     (700,000     —     

Payments on capital lease obligation

     —          (156,621
  

 

 

   

 

 

 

Net cash provided by financing activities

     20,095,716        486,090   
  

 

 

   

 

 

 

Increase (decrease) in cash and cash equivalents

     8,285,641        (1,103,511

Cash and cash equivalents at beginning of period

     2,243,054        1,403,949   
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 10,528,695      $ 300,438   
  

 

 

   

 

 

 

Supplemental cash flow disclosures:

    

Interest paid

   $ 1,181,929      $ 61,532   
  

 

 

   

 

 

 

Income taxes paid

   $ 78,041      $ 19,136   
  

 

 

   

 

 

 

Supplemental Disclosure of Non-Cash Financing and Investing Activities:

 

   

In June 2012, the $3,000,000 convertible note and accrued interest was converted to 1,529,729 common shares at $2.00 per share.

 

   

In August 2012, we issued 393,086 shares of our common stock at a price of $4.07, as part of the Meta acquisition purchase price.

 

   

In October 2012, we issued approximately 200,000 common stock warrants, convertible into common stock shares at $4.06 per share.

 

   

During the third quarter of 2012, we recorded approximately $139,000 of deemed dividends from preferred shares discount accretion.


STREAMLINE HEALTH SOLUTIONS, INC.

Backlog

(Unaudited)

Table A

Backlog

 

     October 31, 2012      January 31, 2012      October 31, 2011  

Streamline Health Software Licenses

   $ 3,650,000       $ 181,000       $ 67,000   

Hardware and Third Party Software

     84,000         194,000         190,000   

Professional Services

     4,348,000         5,945,000         4,946,000   

Software as a service

     19,117,000         10,542,000         6,237,000   

Maintenance and support

     21,535,000         10,504,000         5,374,000   
  

 

 

    

 

 

    

 

 

 

Total

   $ 48,734,000       $ 27,366,000       $ 16,814,000   
  

 

 

    

 

 

    

 

 

 


STREAMLINE HEALTH SOLUTIONS, INC.

Bookings

(Unaudited)

Table B

New bookings (1)

 

     Three Months Ended  
     October 31, 2012  
     Value      % of Total
Bookings
 

Streamline Health Software licenses

   $ —           —  

Software as a service

     2,200,000         76

Maintenance and support

     —           —  

Professional services

     684,000         23

Hardware & third party software

     20,000         1
  

 

 

    

 

 

 

Total bookings

   $ 2,904,000         100
  

 

 

    

 

 

 

 

     Nine Months Ended  
     October 31, 2012  
     Value      % of Total
Bookings
 

Streamline Health Software licenses

   $ 50,000         —  

Software as a service

     9,757,000         86

Maintenance and support

     64,000         1

Professional services

     1,160,000         10

Hardware & third party software

     368,000         3
  

 

 

    

 

 

 

Total bookings

   $ 11,399,000         100
  

 

 

    

 

 

 

 

(1) Bookings are the aggregate of signed contracts and/or completed customer purchase orders approved and accepted by the Company as binding commitments to purchase its products and/or services. New bookings do not include maintenance services as these tend to be recurring in nature on an annual or more frequent basis.


Reconciliation of Non-GAAP Financial Measures

(Unaudited)

Table C

This press release contains a non-GAAP financial measure under the rules of the U.S. Securities and Exchange Commission for adjusted EBITDA. This non-GAAP information supplements and is not intended to represent a measure of performance in accordance with disclosures required by generally accepted accounting principles. Non-GAAP financial measures are used internally to manage the business, such as in establishing an annual operating budget. Non-GAAP financial measures are used by Streamline Health’s management in its operating and financial decision-making because management believes these measures reflect ongoing business in a manner that allows meaningful period-to-period comparisons. Accordingly, the Company believes it is useful for investors and others to review both GAAP and non-GAAP measures in order to (a) understand and evaluate current operating performance and future prospects in the same manner as management does and (b) compare in a consistent manner the company’s current financial results with past financial results. The primary limitations associated with the use of non-GAAP financial measures are that these measures may not be directly comparable to the amounts reported by other companies and they do not include all items of income and expense that affect operations. The Company’s management compensates for these limitations by considering the company’s financial results and outlook as determined in accordance with GAAP and by providing a detailed reconciliation of the non-GAAP financial measures to the most directly comparable GAAP measures in the tables attached to this press release.

Reconciliation of net earnings (loss) to non-GAAP adjusted EBITDA (in thousands)

 

     Three Months Ended,      Nine Months Ended,  
Adjusted EBITDA Reconciliation    October 31,
2012
    October 31,
2011
     October 31,
2012
    October 31,
2011
 

Net earnings

   $ 2,400      $ 296       $ 2,428      $ 8   

Interest expense

     895        26         1,494        68   

Income tax benefit (expense)

     (3,553     5         (3,520     12   

Depreciation and other amortization

     184        163         548        553   

Amortization of capitalized software development costs

     708        454         1,930        1,455   

Amortization of intangible assets

     229        —           254        —     
  

 

 

   

 

 

    

 

 

   

 

 

 

EBITDA

     863        944         3,134        2,096   
  

 

 

   

 

 

    

 

 

   

 

 

 

Stock-based compensation expense

     245        133         645        529   

Transaction expenses

     494        —           1,043        —     
  

 

 

   

 

 

    

 

 

   

 

 

 

Adjusted EBITDA

   $ 1,602      $ 1,077       $ 4,822      $ 2,625   
  

 

 

   

 

 

    

 

 

   

 

 

 

Adjusted EBITDA per diluted share

         

Earnings per share - diluted

   $ 0.15      $ 0.03       $ 0.18      $ 0.00   
  

 

 

   

 

 

    

 

 

   

 

 

 

Adjusted EBITDA per adjusted diluted share

   $ 0.10      $ 0.11       $ 0.39      $ 0.27   
  

 

 

   

 

 

    

 

 

   

 

 

 

Diluted weighted average shares

     15,365,238        9,958,947         12,417,256        9,837,750